Sierra Bancorp reports higher net income
Sierra Bancorp, parent company of the Bank of the Sierra, had diluted earnings per share of 41 cents for the third quarter of 2017, the company announced in its earnings report on Oct. 23. In a news release, the company said it had consolidated net income of $5.7 million for the third quarter of 2017 Read More →
Read More →Investor sues Deckers over board member slate, annual meeting
Deckers Brands investor Marcato Capital Management has filed a lawsuit against the company to get a new slate of board members approved and ensure that its annual shareholder meeting will take place as planned on Dec. 14. Marcato purchased around 6 percent of the Goleta Ugg boot-maker’s stock in February and now owns around 8.4 Read More →
Read More →Citizens Business Bank reports higher net income
CVB Financial and its subsidiary, Citizens Business Bank, saw net income rise for the quarter ended Sept. 30, it announced on Oct. 19. In a news release, the bank reported a net income of $29.7 million or 27 cents per share, an increase from $28.4 million for the second quarter of 2017 and $25.4 million Read More →
Read More →Amgen studying genes to target pain conditions
For the next year, Amgen and Boston Children’s Hospital will use genetic analysis to study pain sensitivity. The biotech giant based in Thousand Oaks will work with patients who have abnormal pain conditions, and the hospital will validate genetic markers as potential targets for new therapies, the two announced in a press release on Oct. 16. “Traditional Read More →
Read More →Calavo Growers to pay 95 cent dividend to shareholders
Santa Paula avocado distributor Calavo Growers announced Oct. 4 that it would pay a 95 cent dividend to shareholders, for a total of $16.7 million. Shareholders of record as of Nov. 17 will receive the dividend on Dec. 8. The company said in a news release that it was the sixth year that it had Read More →
Read More →Mannkind stock soars over new label info for Afrezza
Westlake Village biotech company Mannkind received approval to update the prescribing information for its inhalable insulin product, Afrezza, making it easier to market to customers. The new label information clarifies starting and adjusting mealtime dosages, as well as initial and peak effects, and helps the company avoid confusing language, CEO Michael Castagna said in a Read More →
Read More →CalAmp reports revenue decline but net income up
Information technology company CalAmp reported on Sept. 28 a slight drop in revenue for its second quarter but a dramatic increase in net income, bringing in $12.2 million, or 34 cents per share. The company, which has operations in Oxnard, brought in $89.8 million during the quarter, down slightly from $90.5 million in the second Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
